Pleasurable music activates cerebral µ-opioid receptors: a combined PET-fMRI study
European Journal of Nuclear Medicine and Molecular Imaging · 2025
DOI: 10.1007/s00259-025-07232-z ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Vesa Putkinen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Turku PET Centre, and Turku University Hospital, University of Turku, Turku, Finland. vesa.putkinen@utu.fi. Hauptthemen laut MEDLINE: Receptors, Opioid, mu, Positron-Emission Tomography, Music, Magnetic Resonance Imaging. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The research council of Finland, University of Turku.
Abstract (Originalsprache)
Purpose
The μ-opioid receptor (MOR) system mediates incentive motivation and the hedonic component of primary rewards such as food and sex. However, there is no direct in vivo evidence for the involvement of the MOR system in pleasure derived from aesthetic rewards such as music.
Methods
We measured MOR availability with positron emission tomography (PET) and the agonist radioligand [ 11 C]carfentanil with high affinity for MORs during the listening of pleasurable music and neutral baseline condition. Haemodynamic responses associated with dynamic pleasure ratings during listening to music and control stimuli were measured using functional magnetic resonance imaging (fMRI).
Results
The PET results revealed that pleasurable music increased [ 11 C]carfentanil binding in several cortical and subcortical regions, including ventral striatum and orbitofrontal cortex, known to contain “hedonic hotspots”. [ 11 C]carfentanil binding in the nucleus accumbens during the music condition was associated with number of pleasurable chills, linking the subjective experience of pleasure to striatal opioid release. Individual variation in baseline MOR tone influenced pleasure-dependent haemodynamic responses during music listening in regions associated with interoceptive, sensorimotor, and reward processing.
Conclusions
These findings provide the first neuroimaging evidence that pleasurable music modulates MOR system function. The results indicate that the μ-opioid system governs complex aesthetic rewards in addition to biologically essential primary rewards.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Turku PET Centre, and Turku University Hospital, University of Turku, Turku, Finland. vesa.putkinen@utu.fi.
- Turku Institute for Advanced Studies, University of Turku, Turku, Finland. vesa.putkinen@utu.fi.
- Turku PET Centre, and Turku University Hospital, University of Turku, Turku, Finland.
- Department of Medical Physics, Turku University Hospital, Turku, Finland.
- Department of Radiology, Turku University Hospital, University of Turku, Turku, Finland.
- Medical Imaging Center, Department of Radiology, Tampere University and Tampere University Hospital, Tampere, Finland.
ORCID-Profile: Vesa Putkinen
Förderung
- The research council of Finland
- University of Turku
Zitieren
APA
Putkinen, V., Seppälä, K., Harju, H., Hirvonen, J., Karlsson, H. K., & Nummenmaa, L. (2025). Pleasurable music activates cerebral µ-opioid receptors: a combined PET-fMRI study. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07232-z
Vancouver
Putkinen V, Seppälä K, Harju H, Hirvonen J, Karlsson HK, Nummenmaa L. Pleasurable music activates cerebral µ-opioid receptors: a combined PET-fMRI study. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07232-z
BibTeX
@article{Putkinen2025,
author = {Putkinen, Vesa and Seppälä, Kerttu and Harju, Harri and Hirvonen, Jussi and Karlsson, Henry K and Nummenmaa, Lauri},
title = {Pleasurable music activates cerebral µ-opioid receptors: a combined PET-fMRI study},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2025},
doi = {10.1007/s00259-025-07232-z}
}
EUVIMED